-
Sickle Cell Disease Treatment Market Research Report 2025-2035 | R&D Review, Patent Filling Trends, Regulatory Requirements, Pipeline Analysis - ResearchAndMarkets.com
04 Jul 2025 11:29 GMT
… Pfizer Inc., bluebird bio, Inc., Generex Biotechnology Corporation, Emmaus Life Sciences, Inc …
Pfizer, Inc.
Bluebird bio, Inc,
Generex Biotechnology
Emmaus Life Sciences, Inc.
Bristol …
-
Sickle Cell Disease Treatment Market Analysis And Forecast, 2025-2035 Intensifying Competition As Key Players Advance Gene And Novel Therapies
27 Jun 2025 10:04 GMT
… Pfizer Inc., bluebird bio, Inc., Generex Biotechnology Corporation, Emmaus Life Sciences, Inc … Pfizer, Inc. Bluebird bio, Inc, Generex Biotechnology Emmaus Life Sciences, Inc. Bristol …
-
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen(R) Wound Conforming Matrix in Malaysia
03 May 2021 13:05 GMT
… Chief Operating Officer of Generex Biotechnology Corporation, adds "Getting … network."
About Generex Biotechnology Corp.
Generex Biotechnology is an integrated healthcare … Act.
Generex Contact:
Generex Biotechnology Corporation
Joseph Moscato
646- …
-
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia
03 May 2021 13:00 GMT
… Chief Operating Officer of Generex Biotechnology Corporation, adds “Getting … hospital network.” About Generex Biotechnology Corp.
Generex Biotechnology is an integrated healthcare … Act. Generex Contact: Generex Biotechnology Corporation Joseph Moscato
646 …
-
Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women
08 Apr 2021 13:00 GMT
… using genetic material. Generex Biotechnology Corporation’s majority owned … ;www.lastchanceforchildren.org About Generex Biotechnology Corp.
Generex Biotechnology Corporation (OTCQB: GNBT) … Oncology, a subsidiary of Generex Biotechnology, is a clinical …
-
Generex Biotechnology Announces Shareholder Conference Call Scheduled for Thursday May 6, 2021
31 Mar 2021 15:03 GMT
… attention of the management of Generex Biotechnology Corporation (the “Company”) … call date. About Generex Biotechnology Corp. Generex Biotechnology is an integrated healthcare … Act. Generex Contact: Generex Biotechnology Corporation Joseph Moscato
646- …
-
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM
03 Feb 2021 14:00 GMT
… 518-9865
Program Title: Generex Biotechnology Conference Call
Conference ID – … on Friday.” About Generex Biotechnology Corp.
Generex Biotechnology is an integrated healthcare … Act.
Generex Contact:
Generex Biotechnology Corporation Joseph Moscato
646- …
-
Generex Biotechnology Announces Investor Conference Call Scheduled for Friday February 5, 2021 at 9:00 AM
08 Jan 2021 19:22 GMT
… 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) ( … meeting date. About Generex Biotechnology Corp. Generex Biotechnology is an integrated healthcare … Act. Generex Contact: Generex Biotechnology Corporation Joseph Moscato
646- …
-
Bintai Kinden partner Generex Biotech files trademark, patent for Covid-19 vaccine
07 Jan 2021 15:49 GMT
… Kinden Corp Bhd’s partner Generex Biotechnology Corp has filed for a …
-
Bintai Kinden partner Generex Biotechnology in US$50 million deal for Ii-Key vaccine platform technology
19 Nov 2020 17:17 GMT
… Kinden Corp Bhd’s partner Generex Biotechnology Corp has signed a US …
About
© 1995-2025